顔写真

PHOTO

Oogaki Ryuuichi
大垣 隆一
Oogaki Ryuuichi
大垣 隆一
Graduate School of Medicine Division of Medicine, Associate Professor

Research History 7

  1. 2021/03 - Present
    大阪大学大学院 医学系研究科 准教授

  2. 2020/09 - Present
    大阪大学先導的学際研究機構 生命医科学融合フロンティア研究部門(兼任)

  3. 2016/04 - 2021/02
    大阪大学大学院 医学系研究科 学部内講師

  4. 2009/04 - 2021/02
    大阪大学大学院 医学系研究科 助教

  5. 2009/03 - 2009/03
    Osaka University Graduate School of Medicine Postdoctral fellow

  6. 2008/02 - 2009/02
    Groningen University University Medical Center Groningen Visiting research felllow

  7. 2007/11 - 2009/02
    Osaka University Graduate School of Science Postdoctral fellow

Education 3

  1. Osaka University Graduate School of Science Department of Biological Science, PhD course

    2004/04 - 2007/10

  2. Osaka University Graduate School, Division of Natural Science Department of Biological Science, MS course

    2002/04 - 2004/03

  3. Osaka University Faculty of Science Department of Biological Science

    1998/04 - 2002/03

Committee Memberships 2

  1. Discover Oncology, Editorial Borad Member

    2024/03 - Present

  2. 公益社団法人 日本薬理学会 学術評議員 Academic society

    2016/04 - Present

Professional Memberships 6

  1. 日本癌学会

  2. JAPANESE SOCIETY FOR AMINO ACID SCIENCES

  3. The Japanese Pharmacological Society

  4. The Japanese Society for Investigative Dermatology

  5. THE MOLECULAR BIOLOGY SOCIETY OF JAPAN

  6. The Japanese Biochemical Society

Research Areas 6

  1. Life sciences / Cell biology /

  2. Life sciences / Developmental biology /

  3. Life sciences / Medical biochemistry /

  4. Life sciences / Dermatology /

  5. Life sciences / Pharmacology /

  6. Life sciences / Functional biochemistry /

Awards 4

  1. 令和4年度 膵臓病研究奨励賞

    大垣隆一 公益財団法人 日本膵臓病研究財団 2022/12

  2. 第3回 分子腎臓フォーラム 優秀賞

    大垣隆一 2012/09

  3. The 21st COE Program Research Assistant Progress Report Best Poster Award

    大垣隆一 Biological Science/Institute for Protein Research, Graduate School of Science, Osaka University 2006/09

  4. 楠本賞

    大垣隆一 大阪大学 2002/03

Papers 46

  1. Structural basis of anticancer drug recognition and amino acid transport by LAT1

    Yongchan Lee, Chunhuan Jin, Ryuichi Ohgaki, Minhui Xu, Satoshi Ogasawara, Rangana Warshamanage, Keitaro Yamashita, Garib Murshudov, Osamu Nureki, Takeshi Murata, Yoshikatsu Kanai

    Nature Communications Vol. 16 No. 1 2025/02/14 Research paper (scientific journal)

    Publisher: Springer Science and Business Media LLC
  2. The role of LAT1 in AOM/DSS-induced colorectal tumorigenesis

    Yunlong Sui, Namiko Hoshi, Norihiro Okamoto, Yuta Inoue, Takumi Funatsu, Yuna Ku, Makoto Ooi, Daisuke Watanabe, Haruka Miyazaki, Misaki Agawa, Hirotaka Nakamura, Ryuichi Ohgaki, Yoshikatsu Kanai, Hui Yang, Yuzo Kodama

    Biochemical and Biophysical Research Communications p. 151446-151446 2025/02 Research paper (scientific journal)

    Publisher: Elsevier BV
  3. Pharmacological and structural insights into nanvuranlat, a selective LAT1 (SLC7A5) inhibitor, and its N-acetyl metabolite with implications for cancer therapy

    Chunhuan Jin, Xinyu Zhou, Minhui Xu, Hiroki Okanishi, Ryuichi Ohgaki, Yoshikatsu Kanai

    Scientific Reports Vol. 15 No. 1 2025/01/23 Research paper (scientific journal)

    Publisher: Springer Science and Business Media LLC
  4. Amino acid transporter LAT1 is expressed on cancer cell-derived exosomes with potential as a diagnostic and prognostic biomarker

    Yumiao Liu, Ryuichi Ohgaki, Hiroki Okanishi, Minhui Xu, Yoshikatsu Kanai

    Scientific Reports Vol. 14 2024/11/18 Research paper (scientific journal)

  5. LAT1 expression in colorectal cancer cells is unresponsive to HIF-1/2α accumulation under experimental hypoxia

    Ryuichi Ohgaki, Yuma Hirase, Minhui Xu, Hiroki Okanishi, Yoshikatsu Kanai

    Scientific Reports Vol. 14 2024/08 Research paper (scientific journal)

  6. Upregulation of ATF4 mediates the cellular adaptation to pharmacologic inhibition of amino acid transporter LAT1 in pancreatic ductal adenocarcinoma cells

    Yu Ma, Suguru Okuda, Hiroki Okanishi, Minhui Xu, Chunhuan Jin, Hitoshi Endou, Ryuichi Ohgaki, Yoshikatsu Kanai

    Journal of Pharmacological Sciences Vol. 155 No. 1 p. 14-20 2024/05 Research paper (scientific journal)

    Publisher: Elsevier BV
  7. Identification of tumor-suppressive miRNAs that target amino acid transporter LAT1 and exhibit anti-proliferative effects on cholangiocarcinoma cells

    Xingming Liu, Kou Nishikubo, Ryuichi Ohgaki, Hiroki Okanishi, Suguru Okuda, Minhui Xu, Yoshikatsu Kanai

    Journal of Pharmacological Sciences Vol. 154 No. 4 p. 301-311 2024/04 Research paper (scientific journal)

    Publisher: Elsevier BV
  8. Inhibition of amino acid transporter LAT1 in cancer cells suppresses G0/G1-S transition by downregulating cyclin D1 via p38 MAPK activation

    Xinyu Zhou, Ryuichi Ohgaki, Chunhuan Jin, Minhui Xu, Hiroki Okanishi, Hitoshi Endou, Yoshikatsu Kanai

    Journal of Pharmacological Sciences Vol. 154 No. 3 p. 182-191 2024/03 Research paper (scientific journal)

    Publisher: Elsevier BV
  9. Structure–activity characteristics of phenylalanine analogs selectively transported by L-type amino acid transporter 1 (LAT1)

    Sihui Chen, Chunhuan Jin, Ryuichi Ohgaki, Minhui Xu, Hiroki Okanishi, Yoshikatsu Kanai

    Scientific Reports Vol. 14 No. 1 2024/02/26 Research paper (scientific journal)

    Publisher: Springer Science and Business Media LLC
  10. Evaluation of LAT1 Expression in Patients With Lung Cancer and Mediastinal Tumors: 18F-FBPA PET Study With Immunohistological Comparison.

    Tadashi Watabe, Naoko Ose, Sadahiro Naka, Eriko Fukui, Toru Kimura, Takashi Kanou, Soichiro Funaki, Hidetaka Sasaki, Takashi Kamiya, Kenta Kurimoto, Kayako Isohashi, Mitsuaki Tatsumi, Eku Shimosegawa, Hiroki Kato, Ryuichi Ohgaki, Yoshikatsu Kanai, Yasushi Shintani

    Clinical nuclear medicine Vol. 48 No. 10 p. 853-860 2023/10/01 Research paper (scientific journal)

  11. The Clinical Potential of FBPA-PET/CT Imaging for Colorectal Cancer and its Liver Metastases Expressing LAT1.

    Takayuki Minoji, Hidekazu Takahashi, Tadashi Watabe, Satoshi Ishikawa, Hiroki Kato, Ryuichi Ohgaki, Yoshikatsu Kanai, Yuki Sekido, Tsuyoshi Hata, Atsushi Hamabe, Takayuki Ogino, Norikatsu Miyoshi, Mamoru Uemura, Hirofumi Yamamoto, Yuichiro Doki, Hidetoshi Eguchi

    Anticancer research Vol. 43 No. 9 p. 3913-3921 2023/09 Research paper (scientific journal)

  12. Inhibition of Cancer-type Amino Acid Transporter LAT1 Suppresses B16-f10 Melanoma Metastasis in Mouse Models.

    Zitong Shi, Kazuko Kaneda-Nakashima, Ryuichi Ohgaki, Minhui Xu, Hiroki Okanishi, Hitoshi Endou, Shushi Nagamori, Yoshikatsu Kanai

    Scientific Reports Vol. 13 No. 1 p. 13943-13943 2023/08/25 Research paper (scientific journal)

  13. Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells.

    Kou Nishikubo, Ryuichi Ohgaki, Xingming Liu, Hiroki Okanishi, Minhui Xu, Hitoshi Endou, Yoshikatu Kanai

    Cancer Cell International Vol. 23 No. 1 2023/06 Research paper (scientific journal)

    Publisher: Springer Science and Business Media LLC
  14. LAT1 expression influences Paneth cell number and tumor development in ApcMin/+ mice

    Yunlong Sui, Namiko Hoshi, Ryuichi Ohgaki, Lingling Kong, Ryutaro Yoshida, Norihiro Okamoto, Masato Kinoshita, Haruka Miyazaki, Yuna Ku, Eri Tokunaga, Yuki Ito, Daisuke Watanabe, Makoto Ooi, Masakazu Shinohara, Kengo Sasaki, Yoh Zen, Takenori Kotani, Takashi Matozaki, Zibin Tian, Yoshikatsu Kanai, Yuzo Kodama

    Journal of Gastroenterology 2023/02/05 Research paper (scientific journal)

    Publisher: Springer Science and Business Media LLC
  15. Phosphoproteomics revealed cellular signals immediately responding to disruption of cancer amino acid homeostasis induced by inhibition of l-type amino acid transporter 1

    Hiroki Okanishi, Ryuichi Ohgaki, Minhui Xu, Hitoshi Endou, Yoshikatsu Kanai

    Cancer & Metabolism Vol. 10 No. 1 p. 18-18 2022/11/10 Research paper (scientific journal)

    Publisher: Springer Science and Business Media LLC
  16. Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells

    Kou Nishikubo, Ryuichi Ohgaki, Hiroki Okanishi, Suguru Okuda, Minhui Xu, Hitoshi Endou, Yoshikatsu Kanai

    Journal of Cellular and Molecular Medicine Vol. 26 No. 20 p. 5246-5256 2022/10 Research paper (scientific journal)

    Publisher: Wiley
  17. Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2

    Takafumi Kato, Tsukasa Kusakizako, Chunhuan Jin, Xinyu Zhou, Ryuichi Ohgaki, LiLi Quan, Minhui Xu, Suguru Okuda, Kan Kobayashi, Keitaro Yamashita, Tomohiro Nishizawa, Yoshikatsu Kanai, Osamu Nureki

    Nature Communications Vol. 13 No. 1 2022/08/11 Research paper (scientific journal)

    Publisher: Springer Science and Business Media LLC
  18. Functional coupling of organic anion transporter OAT10 (SLC22A13) and monocarboxylate transporter MCT1 (SLC16A1) influencing the transport function of OAT10

    Naoko Ohtsu, Ryuichi Ohgaki, Chunhuan Jin, Minhui Xu, Hiroki Okanishi, Ryo Takahashi, Akiko Matsui, Wataru Kishimoto, Naoki Ishiguro, Yoshikatsu Kanai

    Journal of Pharmacological Sciences Vol. 150 No. 1 p. 41-48 2022/06/17 Research paper (scientific journal)

    Publisher: Elsevier BV
  19. Proteomics and phosphoproteomics reveal key regulators associated with cytostatic effect of amino acid transporter LAT1 inhibitor

    Hiroki Okanishi, Ryuichi Ohgaki, Suguru Okuda, Hitoshi Endou, Yoshikatsu Kanai

    Cancer Science Vol. 112 No. 2 p. 871-883 2020/12/19 Research paper (scientific journal)

    Publisher: Wiley
  20. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation

    Lili Quan, Ryuichi Ohgaki, Saori Hara, Suguru Okuda, Ling Wei, Hiroki Okanishi, Shushi Nagamori, Hitoshi Endou, Yoshikatsu Kanai

    Journal of Experimental & Clinical Cancer Research Vol. 39 No. 1 2020/12 Research paper (scientific journal)

    Publisher: Springer Science and Business Media LLC
  21. A novel mutation in the SLCO2A1 gene, encoding a prostaglandin transporter, induces chronic enteropathy

    Keisuke Jimbo*, Toshiaki Okuno*, Ryuichi Ohgaki*, Kou Nishikubo, Yuri Kitamura, Yumiko Sakurai, Lili Quan, Hiromichi Shoji, Yoshikatsu Kanai, Toshiaki Shimizu, Takehiko Yokomizo

    PLOS ONE Vol. 15 No. 11 p. e0241869-e0241869 2020/11/09 Research paper (scientific journal)

    Publisher: Public Library of Science (PLoS)
  22. Interaction of halogenated tyrosine/phenylalanine-derivatives with Organic Anion Transporter (OAT) 1 in the renal handling of tumor imaging probes

    Chunhuan Jin, Ling Wei, Ryuichi Ohgaki, Hideyuki Tominaga, Minhui Xu, Suguru Okuda, Hiroki Okanishi, Yasuharu Kawamoto, Xin He, Shushi Nagamori, Yoshikatsu Kanai

    Journal of Pharmacology and Experimental Therapeutics Vol. 375 No. 3 p. 451-462 2020/09/27 Research paper (scientific journal)

    Publisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)
  23. Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc.

    Lee Y, Wiriyasermkul P, Jin C, Quan L, Ohgaki R, Okuda S, Kusakizako T, Nishizawa T, Oda K, Ishitani R, Yokoyama T, Nakane T, Shirouzu M, Endou H, Nagamori S, Kanai Y, Nureki O

    Nature structural & molecular biology Vol. 26 No. 6 p. 510-517 2019/06 Research paper (scientific journal)

  24. Boron delivery for boron neutron capture therapy targeting a cancer-upregulated oligopeptide transporter.

    Miyabe J, Ohgaki R, Saito K, Wei L, Quan L, Jin C, Liu X, Okuda S, Nagamori S, Ohki H, Yoshino K, Inohara H, Kanai Y

    Journal of pharmacological sciences Vol. 139 No. 3 p. 215-222 2019/03 Research paper (scientific journal)

  25. Ratiometric fluorescence imaging of cell surface pH by poly(ethylene glycol)-phospholipid conjugated with fluorescein isothiocyanate

    Ryuichi Ohgaki, Yuji Teramura, Daichi Hayashi, Lili Quan, Suguru Okuda, Shushi Nagamori, Madoka Takai, Yoshikatsu Kanai

    SCIENTIFIC REPORTS Vol. 7 No. 1 2017/12 Research paper (scientific journal)

  26. Essential roles of L-type amino acid transporter 1 in syncytiotrophoblast development by presenting fusogenic 4F2hc

    Ohgaki R, Ohmori T, Hara S, Nakagomi S, Kanai-Azuma M, Kaneda-Nakashima K, Okuda S, Nagamori S, Kanai Y

    Molecular and Cellular Biology Vol. 37 No. 11 2017/06 Research paper (scientific journal)

  27. Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1)

    Kongpracha P, Nagamori S, Wiriyasermkul P, Tanaka Y, Kaneda K, Okuda S, Ohgaki R, Kanai Y

    JOURNAL OF PHARMACOLOGICAL SCIENCES Vol. 133 No. 2 p. 96-102 2017/02 Research paper (scientific journal)

  28. Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder

    Dora C. Tarlungeanu, Elena Deliu, Christoph P. Dotter, Majdi Kara, Philipp Christoph Janiesch, Mariafrancesca Scalise, Michele Galluccio, Mateja Tesulov, Emanuela Morelli, Fatma Mujgan Sonmez, Kaya Bilguvar, Ryuichi Ohgaki, Yoshikatsu Kanai, Anide Johansen, Seham Esharif, Tawfeg Ben-Omran, Meral Topcu, Avner Schlessinger, Cesare Indiveri, Kent E. Duncan, Ahmet Okay Caglayan, Murat Gunel, Joseph G. Gleeson, Gaia Novarino

    CELL Vol. 167 No. 6 p. 1481-+ 2016/12 Research paper (scientific journal)

  29. Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 Inhibitor Canagliflozin with SGLT1 and SGLT2: Inhibition Kinetics, Sidedness of Action, and Transporter-Associated Incorporation Accounting for its Pharmacodynamic and Pharmacokinetic Features

    Ryuichi Ohgaki, Ling Wei, Kazunori Yamada, Taiki Hara, Chiaki Kuriyama, Suguru Okuda, Kiichiro Ueta, Masaharu Shiotani, Shushi Nagamori, Yoshikatsu Kanai

    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 358 No. 1 p. 94-102 2016/07 Research paper (scientific journal)

  30. Structure-activity relations of leucine derivatives reveal critical moieties for cellular uptake and activation of mTORC1-mediated signaling

    Shushi Nagamori, Pattama Wiriyasermkul, Suguru Okuda, Naoto Kojima, Yoshiyuki Hari, Shigeki Kiyonaka, Yasuo Mori, Hideyuki Tominaga, Ryuichi Ohgaki, Yoshikatsu Kanai

    AMINO ACIDS Vol. 48 No. 4 p. 1045-1058 2016/04 Research paper (scientific journal)

  31. Specific transport of 3-fluoro-l--methyl-tyrosine by LAT1 explains its specificity to malignant tumors in imaging

    Ling Wei, Hideyuki Tominaga, Ryuichi Ohgaki, Pattama Wiriyasermkul, Kohei Hagiwara, Suguru Okuda, Kyoichi Kaira, Noboru Oriuchi, Shushi Nagamori, Yoshikatsu Kanai

    CANCER SCIENCE Vol. 107 No. 3 p. 347-352 2016/03 Research paper (scientific journal)

  32. Transport of 3-fluoro-L-alpha-methyl-tyrosine (FAMT) by organic ion transporters explains renal background in [F-18]FAMT positron emission tomography

    Ling Wei, Hideyuki Tominaga, Ryuichi Ohgaki, Pattama Wiriyasermkul, Kohei Hagiwara, Suguru Okuda, Kyoichi Kaira, Yukio Kato, Noboru Oriuchi, Shushi Nagamori, Yoshikatsu Kanai

    JOURNAL OF PHARMACOLOGICAL SCIENCES Vol. 130 No. 2 p. 101-109 2016/02 Research paper (scientific journal)

  33. Novel cystine transporter in renal proximal tubule identified as a missing partner of cystinuria-related plasma membrane protein rBAT/SLC3A1

    Shushi Nagamori, Pattama Wiriyasermkul, Meritxell Espino Guarch, Hirohisa Okuyama, Saya Nakagomi, Kenjiro Tadagaki, Yumiko Nishinaka, Susanna Bodoy, Kazuaki Takafuji, Suguru Okuda, Junko Kurokawa, Ryuichi Ohgaki, Virginia Nunes, Manuel Palacín, Yoshikatsu Kanai

    Proceedings of the National Academy of Sciences of the United States of America Vol. 113 No. 3 p. 775-780 2016/01 Research paper (scientific journal)

  34. Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB(0,+), LAT1 and LAT2

    Printip Wongthai, Kohei Hagiwara, Yurika Miyoshi, Pattama Wiriyasermkul, Ling Wei, Ryuichi Ohgaki, Itsuro Kato, Kenji Hamase, Shushi Nagamori, Yoshikatsu Kanai

    CANCER SCIENCE Vol. 106 No. 3 p. 279-286 2015/03 Research paper (scientific journal)

  35. Nicotine induces dendritic spine remodeling in cultured hippocampal neurons

    Akira Oda, Kanato Yamagata, Saya Nakagomi, Hiroshi Uejima, Pattama Wiriyasermkul, Ryuichi Ohgaki, Shushi Nagamori, Yoshikatsu Kanai, Hidekazu Tanaka

    Journal of Neurochemistry Vol. 128 No. 2 p. 246-255 2014/01 Research paper (scientific journal)

    Publisher: 2
  36. Transport of 3-Fluoro-L-alpha-Methyl-Tyrosine by Tumor-Upregulated L-Type Amino Acid Transporter 1: A Cause of the Tumor Uptake in PET

    Pattama Wiriyasermkul, Shushi Nagamori, Hideyuki Tominaga, Noboru Oriuchi, Kyoichi Kaira, Hidekazu Nakao, Takeru Kitashoji, Ryuichi Ohgaki, Hidekazu Tanaka, Hitoshi Endou, Keigo Endo, Hiroyuki Sakurai, Yoshikatsu Kanai

    JOURNAL OF NUCLEAR MEDICINE Vol. 53 No. 8 p. 1253-1261 2012/08 Research paper (scientific journal)

  37. NRFL-1, the C. elegans NHERF orthologue, interacts with amino acid transporter 6 (AAT-6) for age-dependent maintenance of AAT-6 on the membrane

    Kohei Hagiwara, Shushi Nagamori, Yasuhiro M. Umemura, Ryuichi Ohgaki, Hidekazu Tanaka, Daisuke Murata, Saya Nakagomi, Kazuko H. Nomura, Eriko Kage-Nakadai, Shohei Mitani, Kazuya Nomura, Yoshikatsu Kanai

    PLoS ONE Vol. 7 No. 8 2012/08 Research paper (scientific journal)

    Publisher: 8
  38. Linkage of N-cadherin to multiple cytoskeletal elements revealed by a proteomic approach in hippocampal neurons

    Hidekazu Tanaka, Kazuaki Takafuji, Akihiko Taguchi, Pattama Wiriyasermkul, Ryuichi Ohgaki, Shushi Nagamori, Pann-Ghill Suh, Yoshikatsu Kanai

    NEUROCHEMISTRY INTERNATIONAL Vol. 61 No. 2 p. 240-250 2012/07 Research paper (scientific journal)

  39. Establishment of Stable Cell Lines With High Expression of Heterodimers of Human 4F2hc and Human Amino Acid Transporter LAT1 or LAT2 and Delineation of Their Differential Interaction With alpha-Alkyl Moieties

    Narakorn Khunweeraphong, Shushi Nagamori, Pattama Wiriyasermku, Yumiko Nishinaka, Printip Wongthai, Ryuichi Ohgaki, Hidekazu Tanaka, Hideyuki Tominaga, Hiroyuki Sakurai, Yoshikatsu Kanai

    JOURNAL OF PHARMACOLOGICAL SCIENCES Vol. 119 No. 4 p. 368-380 2012/07 Research paper (scientific journal)

  40. Differential Effects of TNF (TNFSF2) and IFN-gamma on Intestinal Epithelial Cell Morphogenesis and Barrier Function in Three-Dimensional Culture

    Kati Juuti-Uusitalo, Leon J. Klunder, Klaas A. Sjollema, Katarina Mackovicova, Ryuichi Ohgaki, Dick Hoekstra, Jan Dekker, Sven C. D. van Ijzendoorn

    PLOS ONE Vol. 6 No. 8 2011/08 Research paper (scientific journal)

  41. Organellar Na+/H+ exchangers: novel players in organelle pH regulation and their emerging functions.

    Ohgaki R, van IJzendoorn SC, Matsushita M, Hoekstra D, Kanazawa H

    Biochemistry. Vol. 50 No. 4 p. 443-450 2011/02 Research paper (scientific journal)

  42. The Na+/H+ exchanger NHE6 in the endosomal recycling system is involved in the development of apical bile canalicular surface domains in HepG2 cells.

    Ohgaki R, Matsushita M, Kanazawa H, Ogihara S, Hoekstra D, van Ijzendoorn SC

    Mol Biol Cell. Vol. 21 No. 7 p. 1293-1304 2010/04 Research paper (scientific journal)

  43. A membrane-proximal region in the C-terminal tail of NHE7 is required for its distribution in the trans-Golgi network, distinct from NHE6 localization at endosomes.

    Fukura N, Ohgaki R, Matsushita M, Nakamura N, Mitsui K, Kanazawa H

    J Membr Biol Vol. 234 No. 3 p. 149-158 2010/04 Research paper (scientific journal)

  44. Localization, ion transport activity, and physiological function of mammalian organellar NHEs

    Ryuichi Ohgaki, Masafumi Matsushita, Hiroshi Kanazawa

    Seikagaku Vol. 82 No. 7 p. 577-590 2010

    Publisher: 7
  45. Cell Surface Levels of Organellar Na+/H+ Exchanger Isoform 6 Are Regulated by Interaction with RACK1.

    Ohgaki R, Fukura N, Matsushita M, Mitsui K, Kanazawa H

    J Biol Chem. Vol. 283 No. 7 p. 4417-4429 2008/02 Research paper (scientific journal)

  46. Characterization of the ion transport activity of the budding yeast Na+/H+ antiporter, Nha1p, using isolated secretory vesicles.

    Ohgaki R, Nakamura N, Mitsui K, Kanazawa H

    Biochim Biophys Acta. Vol. 1712 p. 185-196 2005/06 Research paper (scientific journal)

    Publisher: 2

Misc. 7

  1. アミノ酸トランスポーター阻害薬によるがん治療 -研究の展開と解明が進むユニークな抗腫瘍効果の発現機序-

    大垣 隆一

    日本応用酵素協会誌 Vol. 56 p. 21-28 2022/03

  2. Cell surface pH imaging using poly(ethylene glycol)-phospholipid: its potential as the core structure of membrane anchored-probes

    大垣隆一, 寺村裕治, 林大智, 永森收志, 永森收志, 高井まどか, 金井好克

    日本薬理学雑誌 Vol. 153 No. 6 p. 254-260 2019/06

  3. アミノ酸シグナルの解明からがん治療へ -アミノ酸トランスポーター阻害によるがん代謝制御-

    大垣隆一, 金井好克

    実験医学 Vol. 37 No. 4 p. 508-513 2019/03 Article, review, commentary, editorial, etc. (trade magazine, newspaper, online media)

  4. Amino acid transporter chaperons its fusogenic partner: an essential role in placenta, and its implications for physiological and pathological cell fusion

    Ryuichi Ohgaki, Yoshikatsu Kanai

    Atlas of Science (http://atlasofscience.org/) 2018/01 Book review, literature introduction, etc.

  5. ロイシンセンサーの分子実体の発見とそれによるmTORC1の活性制御

    大垣 隆一

    ファルマシア Vol. 52 No. 7 p. 696-696 2016/07 Book review, literature introduction, etc.

    Publisher: 公益社団法人 日本薬学会
  6. L-型アミノ酸トランスポーター1(LAT1)による輸送と哺乳類ラパマイシン標的タンパク質(mTOR)活性化のためのロイシン誘導体の構造的必要性(The structural requirements of leucine derivatives to be transported by L-type amino acid transporter 1(LAT1) and to activate mammalian target of rapamycin(mTOR))

    Wiriyasermkul Pattama, 永森 收志, 木村 徹, 大垣 隆一, 金井 好克

    日本薬理学雑誌 Vol. 137 No. 3 p. 31P-31P 2011/03

    Publisher: (公社)日本薬理学会
  7. Localization, ion transport activity, and physiological function of mammalian organellar NHEs

    Ohgaki R, Matsushita M, Kanazawa H

    Vol. 82 No. 7 p. 577-590 2010/07

    Publisher: 日本生化学会

Presentations 146

  1. 低酸素培養条件下での低酸素誘導因子HIF-1/2αの蓄積は大腸がん細胞における必須アミノ酸トランスポーターLAT1の発現を誘導しない

    大垣 隆一, 平瀬 悠真, 徐 旻憓, 岡西 広樹, 金井 好克

    第47回 日本分子生物学会年会 2024/11/29

  2. Effects of the accumulation of hypoxia-inducible factors on the expression of L-type amino acid transporter LAT1 in colorectal cancer cells

    2023/12/14

  3. Structural basis for inhibition of human excitatory amino acid transporter EAAT2 by WAY-213613

    Takafumi Kato, ○Tsukasa Kusakizako, Ryuichi Ohgaki, Yoshikatsu Kanai, Osamu Nureki

    Strufcture, Function, and Dynamics International Conference (SFD Conference 2023)

  4. Amino acid transporter LAT1 (SLC7A5) on cancer cell-derived exosomes as a potential prognostic- and diagnostic biomarker.

    2022/12/02

  5. Evaluation of LAT1 expression in patients with lung cancers and mediastinal tumors: [18F]FBPA PET study with immuno-histopathological comparison

    T. Watabe, N. Ose, S. Naka, E. Fukui, T. Kanou, S. Funaki, H. Sasaki, T. Kamiya, K. Kurimoto, E. Shimosegawa, H. Kato, R. Ohgaki, Y. Kanai, Y. Shintani

    EANM'22 - Annual Congress of the European Association of Nuclear Medicine 2022/10/17

  6. Roles of L-Type amino acid transporter1 in the development of intestinal tumors

    Yunlong Sui, Namiko Hoshi, Ryuichi Ohgak, Yuki Ito, Takenori Kotani, Takashi Matozaki, Yuzo Kodama

    30th United European Gastroenterology Week 2022/10/11

  7. 血管内皮細胞におけるアミノ酸トランスポーターLAT1の発現亢進とVEGF-Aシグナルの制御による腫瘍血管新生への寄与

    大垣隆一

    第3回 生命医科学若手研究者の会 2021/11/12

  8. 腫瘍血管新生におけるアミノ酸トランスポーターLAT1 の機能

    大垣隆一

    第1 回 トランスポーター研究会関西部会 2021/10/30

  9. Influence of genetic variation in SLC7A13/AGT1 in human cystinuria

    Ria Schönauer, Anna Seidel, Linda Pöschla, Elena Helene Hantmann, Soumeya Bekri, Bertra, Knebelmann, John Sayer, Ryuichi Ohgaki, Jan Halbritter

    58th ERA-EDTA (European Renal Association – European Dialysis and Transplant Association) Congress 2021/06/06

  10. Amino acid transporter LAT1 is upregulated in tumor-associated vascular endothelial cells and plays essential roles in tumor angiogenesis by promoting proliferation and regulating VEGF-A-dependent pro-angiogenic mTORC1 activation

    Ryuichi Ohgaki, Lili Quan, Suguru Okuda, Hiroki Okanishi, Shushi Nagamori, Hitoshi Endou, Yoshikatsu Kanai

    第94回 日本薬理学会年会 2021/03/10

  11. アミノ酸トランスポーターが制御するシグナル経路と 腫瘍血管新生における意義

    大垣 隆一

    大阪大学 先導的学際研究機構 生命医科学融合フロンティア研究部門 ライフサイエンス若手研究者の会 2020/07/18

  12. 必須アミノ酸輸送体とオートファジーの共阻害による新規膵臓がん治療法の提唱

    大垣 隆一

    第12回 消化器疾患プロジェクト会議 2020/02/01

  13. ヘテロ二量型アミノ酸トランスポーター複合体LAT1-4F2hcは胎盤の合胞体性栄養膜形成に必須の細胞融合因子である

    大垣隆一, 大森崇弘, 原早織, 中込咲綾, 金井正美, 兼田(中島, 加珠子, 奥田傑, 永森收志, 金井好克

    第66回 日本生化学会近畿支部例会 2019/05/25

  14. Membrane-anchored ratiometric fluorescent probe for visualizing the extracellular juxtamembrane pH

    Ryuichi Ohgaki, Yuji Teramura, Daichi Hayashi, Shushi Nagamori, Madoka Takai, Yoshikatsu Kanai

    The 22nd Japan-Korea Joint Seminar on Pharmacology, Japan-Korea Joint Session of the 92nd Annual Meeting of the Japanese Pharmacological Society 2019/03/16

  15. Cell surface pH imaging using a membrane-anchored ratiometric fluorescence probe: Poly(ethylene glycol)-phospholipid as membrane anchor to investigate the juxtamembrane environment

    Ryuichi Ohgaki, Yuji Teramura, Daichi Hayashi, Shushi Nagamori, Madoka Takai, Yoshikatsu Kanai

    The 92nd Annual Meeting for the Japanese Pharmacological Society 2019/03/15

  16. Essential roles of amino acid transporter LAT1 in cell fusion for the development of placental syncytiotrophoblast

    Ryuichi Ohgaki, Takahiro Ohmori, Saori Hara, Saya Nakagomi, Masami Kanai, Kazuko Kaneda-Nakashima, Suguru Okuda, Shushi Nagamori, Yoshikatsu Kanai

    The 1st OIST-OU Joint Symposium - Cell Biology and Immunology- 2019/01/29

  17. 腫瘍血管内皮細胞における必須アミノ酸 トランスポーターの発現亢進と血管新生への寄与

    大垣隆一

    第2回 がんと代謝研究会若手の会 2019/01/24

  18. アミノ酸トランスポーターによる多様な細胞機能制御と創薬標的としての意義

    大垣隆一

    第393回 大阪大学臨床栄養研究会 2019/01/21

  19. Upregulation of an amino acid transporter LAT1 in tumour-associated blood vessels and its contribution to angiogenesis

    Ryuichi Ohgaki

    Australia Japan Medical Research Symposium September 2018 2018/09/12

  20. 血管内皮細胞におけるアミノ酸トランスポーターLAT1の発現と腫瘍血管新生への寄与

    大垣隆一

    第13回 トランスポーター研究会年会 2018/07/22

  21. Phosphoproteome analysis reveals novel cellular responses affect by inhibition of LAT1, a cancer type amino acid transporter.

    Pornparn Kongpracha, Shushi Nagamori, Pattama Wiriyasermkul, Suguru Okuda, Ryuichi Ohgaki, Yoshikatsu Kanai

    18th World congress of basic and clinical pharmacology 2018/07/05

  22. L-type amino acid transporter 1 (LAT1) in endothelial cells of tumor vessels contributes to tumor angiogenesis

    Lili Quan, Ryuichi Ohgaki, Suguru Okuda, Shushi Nagamori, Yoshikatsu Kanai

    18th World congress of basic and clinical pharmacology 2018/07/05

  23. BPA-dipeptides, novel boron delivery agents for boron neutron capture therapy, are transported by oligopeptide transporter

    Junji Miyabe, Ryuichi Ohgaki, Keijiro Saito, Ling Wei, Suguru Okuda, Shushi Nagamori, Hiroshi Ohki, Kazuo Yoshino, Hidenori Inohara, Yoshikatsu Kanai

    18th World congress of basic and clinical pharmacology 2018/07/05

  24. Combination of amino acids necessary and sufficient for the optimal activation of mTORC1

    Ryuichi Ohgaki, Chunhuan Jin, Suguru Okuda, Shushi Nagamori, Yoshikatsu Kanai

    18th World congress of basic and clinical pharmacology 2018/07/04

  25. Structure activity relations of aromatic amino acid derivatives to interact with organic anion transporter OAT1 reveal critical moieties for renal accumulation of tumor imaging probes

    Chunhuan Jin, Ling Wei, Ryuichi Ohgaki, Hideyuki Tominaga, Suguru Okuda, Shushi Nagamori, Yoshikatsu Kanai

    18th World congress of basic and clinical pharmacology 2018/07/02

  26. アミノ酸トランスポーターを介した代謝制御と細胞機能制御

    大垣隆一, 金井好克

    第72回 日本栄養・食糧学会大会 2018/05/12

  27. 腫瘍血管新生に寄与する血管内皮細胞のアミノ酸トランスポーター

    大垣隆一, Quan Lili, 奥田傑, 永森收志, 金井好克

    第1回 がんと代謝研究会・若手の会 2018/01/16

  28. アミノ酸トランスポーターLAT1は膜融合関連因子4F2hcの細胞膜提示による胎盤合胞体性栄養膜の形成に必須である

    大垣隆一, 大森崇弘, 原早織, 中込咲綾, 金井正美, 兼田(中島, 加珠子, 奥田傑, 永森收志, 金井好克

    第12回 トランスポーター研究会年会 2017/07/08

  29. Inhibition kinetics and inhibitory mechanism of the sodium/glucose cotransporter (SGLT) 2 inhibitor canagliflozin

    The 90th Annual Meeting of the Japanese Pharmacological Society 2017/03/15

  30. Essential roles of LAT1, L-type amino acid transporter 1, in the development of placental syncytiotrophoblast: Importance in cell fusion via the presentation of fusion regulatory protein 4F2hc

    2016/12/01

  31. Amino acid transporter LAT1 as the target of cancer therapeutics and diagnosis

    Ryuichi Ohgaki

    2016/10/19

  32. Cell surface presentation of fusion regulatory protein 4F2hc by amino acid transporter LAT1 is essential for the formation of syncytiotrophoblasts in placenta

    Ryuichi Ohgaki

    2016/09/12

  33. Inhibition kinetics, sidedness of action, and transporter-mediated uptake of the sodium/glucose cotransporter (SGLT) 2 inhibitor canagliflozin: implications for its pharmacodynamic and pharmacokinetic features

    Ling Wei, Ryuichi Ohgaki, Kazunori Yamada, Taiki Hara, Chiaki Kuriyama, Suguru Okuda, Kiichiro Ueta, Masaharu shiotani, Shushi Nagamori, Yoshikatsu Kanai

    International and Interdisciplinary Symposium 2016 “Towards a New Era of Cardiovascular Research” 2016/07/12

  34. PEG結合リン脂質型蛍光分子プローブの 細胞膜表層pHイメージングツールとしての有用性の検討

    大垣 隆一, 寺村 裕治, 林 大智, 永森 收志, 高井 まどか, 金井 好克

    H28年度 生理研研究会(第5回 生体界面研究会) 2016/07/05

  35. PEG結合リン脂質型蛍光分子プローブによる細胞膜表層pHのイメージング

    大垣 隆一, 寺村 裕治, 林 大智, 永森 收志, 高井 まどか, 金井 好克

    第129回 日本薬理学会近畿部会 2016/06/24

  36. Inhibition kinetics, sidedness of action, and transporter-mediated uptake of the sodium/glucose cotransporter (SGLT) 2 inhibitor canagliflozin: implications for its pharmacodynamic and pharmacokinetic features

    Ohgaki R, Wei L, Yamada K, Hara T, Kuriyama C, Okuda S, Ueta K, Leclercq L, Mamidi RN, Shiotani M, Nagamori S, Kanai Y

    76th American Diabetes Association Scientific Sessions 2016/06/12

  37. Properties of mTORC1 regulation by amino acid signaling in HEK293T cells

    2015/12/03

  38. Study on the transport of SGLT2 inhibitor canagliflozin by human SGLT2 and its inhibitory action from extracellular and intracellular sides

    2015/05/21

  39. Inhibition of L-type amino acid transporter 1 exerts anti-angiogenic effects

    2015/03/18

  40. Characterization of intestinal amino acid transporter AAT-6 in C. elegans

    Daisuke Murata, Ryuichi Ohgaki, Kohei Hagiwara, Kanokporn Phetdee, Shushi Nagamori, Ling Wei, Taku Hirata, Kazuya Nomura, Shohei Mitani, Yoshikatsu Kanai

    C. elegans Development, Cell Biology and Gene Expression Meeting in association with The 6th Asia-Pacific C. elegans Meeting 2014/07/17

  41. アミノ酸トランスポーターLAT1の阻害薬による血管新生抑制効果の検討

    大垣 隆一, 原 早織, Printip Wongthai, 中込 咲綾, 永森 收志, 金井 好克

    第125回 日本薬理学会近畿部会 2014/06/20

  42. Transport of 3-fluoro-L--methyltyrosine (FAMT) by amino acid transports and organic ion transporters explains cancer-specificity and renal background in 18F-FAMT PET

    5th Asia Pacific ISSX Meeting 2014 2014/05/10

  43. Midgestational lethality in mice lacking LAT1, large neutral amino acid transporter 1, is associated with abnormal blood vessel formation and defective placental development.

    2013/09/11

  44. A novel cystine transporter in S3 segment of the renal proximal tubule is an “unknown-partner” of Slc3a1 (rBAT).

    Shushi Nagamori, Pattama Wiriyasermkul, Meritxell Espino Guarch, Kazuhisa Okuyama, Saya Nakagomi, Kenijiro Tadagaki, Kazuaki Takafuji, Ryuichi Ohgaki, Manuel Palacin, Yoshikatsu Kanai

    2nd HDP international symposium on Multi-Level Systems Biology 2013/06/28

  45. Age-dependent maintenance of transportsome in C. elegans.

    Kohei Hagiwara, Shushi Nagamori, Yasuhiro M. Umemura, Ryuichi Ohgaki, Yoshikatsu Kanai

    第1回 Awaji International Workshop on “Electron Spin Science & Technology: Biological and Materials Science Oriented Applications 2013/06/16

  46. 腎尿細管に残された第二のシスチントランスポーターの分子同定

    大垣 隆一, 奥山 裕久, Pattama Wiriyasermkul, 中 込 咲綾, 西中 由美子, 高藤 和輝, 永森 收志, 金 井 好克

    第3回分子腎臓フォーラム 2012/09/01

  47. Functional coupling between a Na+-dependent anion transporter SMCT2 and a urate-anion exchanger URAT1 through a scaffold protein PDZK1.

    Nagamori S, Umemura Y, Wiriyasermkul P, Nakagomi S, Nishinaka Y, Takafuji K, Ohgaki R, Kanai Y

    Gordon Research Conferences, Membrane Transport Proteins. 2012/07/04

  48. 表皮バリア形成に必須の 新規リパーゼ様タンパク質mYEH2の役割

    大垣隆一

    花王芸術科学財団 第14回 助成研究発表・交流会 2012/06/06

  49. Na+/H+ exchanger isoform 6 controls the development of apical bile canalicular domains in hepatic HepG2 cells

    2009/10/21

  50. STIMULStimulation of amino acids to grwoth signal in HEK293TATION OF AMINO ACIDS TO GROWTH SIGNAL IN HEK293T

    Ryuichi Ohgaki, Narakorn Khunweeraphong, Yoshikatsu Kanai, Shushi Nagamori, Taku Hirata

    36th International congress of physiological sciences IUPS2009 2009/07/27

  51. Na+/H+交換輸送体NHE6に相互作用し機能調節に関わる新規因子RACK1の発見

    大垣隆一, 三井慶治, 松下昌史, 金澤 浩

    BMB2008 (第31回 日本分子生物学会年会、第81回日本生化学会大会合同大会) 2008

  52. Scaffold タンパク質RACK1 によるオルガネラ膜Na+/H+交換輸送体の局在・機能制御

    大垣隆一, 福良尚美, 松下昌史, 三井慶治, 金澤浩

    日本生体エネルギー研究会 第33回討論会 2007

  53. Intracellular distribution of organellar Na+/H+ exchanger isoform 6 is regulated by the interaction with receptor for activated C-kinase 1 (RACK1)

    2007

  54. オルガネラ膜Na+/H+交換輸送体の相互作用因子の探索と機能解析

    大垣隆一, 福良尚美, 松下昌史, 三井慶治, 金澤浩

    第1回 トランスポーター研究会 2006

  55. Screening and identification of a protein interacting with organellar Na+/H+ exchangers

    2006

  56. オルガネラ膜NHEアイソフォームを用いた複数回膜貫通蛋白質の細胞内局在制御機構の解析

    大垣隆一, 福良尚美, 中村徳弘, 三井慶治, 金澤浩

    第52回 日本生化学会近畿支部例会 2005

  57. Ion transport activity of reconstituted mammalian organellar Na+/H+ exchangers

    Yoshinori Teko, Ryuichi Ohgaki, Norihiro Nakamura, Keiji Mitsui, Masafumi Matsushita, Hiroshi Kanazawa

    International Symposium on Biological Membrane Transport 2005 2005

  58. Characterization of the ion transport activity of yeast Na+/H+ antiporter using isolated secretory vesicles.

    Ryuichi Ohgaki, Norihiro Nakamura, Keiji Mitsui, Masafumi Matsushita, Hiroshi Kanazawa

    International Symposium on Biological Membrane Transport 2005 2005

  59. オルガネラ膜Na+/H+交換輸送体の細胞内局在決定部位の同定

    大垣隆一, 福良尚美, 中村徳弘, 三井慶治, 金澤浩

    第27回 日本分子生物学会年会 2004

  60. 細胞内小胞に存在するNa+/H+交換輸送蛋白質の局在化の機構

    大垣隆一, 福良尚美, 中村徳弘, 金澤浩

    第30回 日本生体エネルギー研究会 2004

  61. Measurement of ion transport activity of yeasat plasma membrane Na+/H+ antiporter on secretory vesicle

    大垣隆一, 三井慶治, 中村徳弘, 井上弘樹, 金澤浩

    第29回 日本生体エネルギー研究会 2003

  62. 出芽酵母のNa+/H+交換輸送担体の分泌小胞上におけるイオン輸送活性の測定

    大垣隆一, 三井慶治, 中村徳弘, 井上弘樹, 金澤浩

    第50回 日本生化学会近畿支部会 2003

  63. Functional roles of conserved domains in the diverse hydrophilic carboxy-terminal halves of yeast Na+/H+ antiporters (Nha1p)

    Hiroshi Kanazawa, K.eiji Mitsui, Shinya Kamauchi, Norihiro Nakamura, Fumihiro Ochi, Ryuichi Ohgaki, Hiroki Inoue

    12th European Bioenergetics Conference 2002

  64. Roles of the hydrophilic tail domain of Na+/H+ antiporter in yeast

    Keiji Mitsui, Hirofumi Ochi, Ryuichi Ohgaki, Norihiro Nakamura, Hiroki Inoue, Hiroshi Kanazawa

    International symposium on Membrane Transporter, 1st JBS Biofrontier Symposum 2002

  65. 出芽酵母のNa+/H+交換輸送担体の分泌小胞上における活性測定

    大垣隆一, 三井慶治, 越智史博, 中村徳弘, 井上弘樹, 金澤浩

    第75回 日本生化学会大会 2002

  66. アミノ酸トランスポーターを標的としたがん治療の可能性:抗腫瘍効果の基盤となる多様な機序の存在

    大垣 隆一

    第20回 横断的腫瘍フォーラム 2022/01/11

  67. 虚血性網膜症の器官培養系解析モデルの確立と新規治療法の提唱

    大垣隆一, 福嶋葉子, 松本真司

    先導的学際研究機構 生命医科学融合フロンティア研究部門 研究報告会 2021/03/19

  68. Anti-cancer pharmacological effects of nanvuranlat, an inhibitor for amino acid transporter LAT1, mediated by sustained reduction in intracellular valine and isoleucine in cancer cells

    2025/03/19

  69. Mechanisms of the inhibition of cancer cell proliferation by LAT1 inhibitors revealed by the changes in the intracellular concentrations and function of individual amino acids

    2023/12/15

  70. Functional coupling with endogenous monocarboxylic acid transporter MCT1 influences on transport function of exogenously expressed organic anion transporter OAT10 in HEK293 cells: a warning on transporter assays

    2023/12/14

  71. Enhancing Anti-tumor Effect of PD-1 Inhibitors through T-Cell Activation by Amino Acid Transporter LAT1 Inhibitor

    Minhui Xu, Xinyu Zhou, Chunhuan Jin, Hiroki Okanishi, Ryuichi, Ohgaki, Hitoshi Endou, Yoshikatsu Kanai

    2023/09/21

  72. Inhibition of amino acid transporter LAT1 drastically suppresses the transport of large neutral amino acids and induces the downregulation of global translation in cancer cells

    2022/11/30

  73. がん特異的アミノ酸トランスポーターLAT1 阻害薬JPH203 による胆道がん細胞内 アミノ酸プールの破綻に伴うリン酸化プロテオーム解析

    岡西 広樹, 大垣 隆一, Xu Minhui, 遠藤 仁, 金井 好克

    第142回 日本薬理学会近畿部会 2022/11/12

  74. Involvement of L-type amino acid transporter 1 in the development of intestinal tumors

    Yunlong Sui, Namiko Hoshi, Ryuichi Ohgaki, Yuki Ito, Takenori Kotani, Takashi Matozaki, Yuzo Kodama

    The 81st Annual Meeting of the Japanese Cancer Association 2022/10/01

  75. アミノ酸トランスポーターLAT1阻害薬が腫瘍細胞の大型中性アミノ酸輸送とタンパク質合成に与える影響

    西窪 航, 大垣 隆一, 岡西 広樹, 奥田 傑, 徐 旻憓, 遠藤 仁, 金井 好克

    第141回 日本薬理学会近畿部会 2022/07/01

  76. Contribution of LAT1 to amino acid uptake in cancer cells and suppression of cellular protein synthesis by LAT1 inhibitor

    The 95th Annual Meeting of the Japanese Pharmacology Society 2022/03/07

  77. 胆道がん細胞株におけるアミノ酸トランスポーターLAT1阻害薬が示す増殖抑制作用のタンパク質発現・リン酸化変動の網羅的解析による検討

    岡西広樹, 大垣隆一, 奥田傑, 遠藤仁, 金井好克

    第140回 日本薬理学会近畿部会 2021/11/13

  78. アミノ酸トランスポーターLAT1阻害薬JPH203による胆道がん細胞増殖抑制機構に関わるプロテオミクスおよびリン酸化プロテオミクス解析

    岡西 広樹, 大垣 隆一, 奥田 傑, 遠藤 仁, 金井 好克

    第94回日本生化学会大会 2021/11/03

  79. Time-course analysis of the changes in intracellular amino acid concentrations and amino acid-related signaling pathways in cancer cells induced by the inhibition of cancer-type amino acid transporter LAT1

    2020/03/16

  80. Suppression of LAT1 in endothelial cells of tumor tissues exhibits an anti-angiogenesis effect

    Lili Quan, Ryuichi Ohgaki, Suguru Okuda, Shushi Nagamori, Yoshikatsu Kanai

    第93回 日本薬理学会年会 2020/03/16

  81. Critical moieties of aromatic amino acid probes causing renal accumulation in tumor imaging

    Chunhuan Jin, Ling Wei, Ryuichi Ohgaki, Suguru Okuda, Shushi Nagamori, Yoshikatsu Kanai

    第93回 日本薬理学会年会 2020/03/16

  82. Identification of miRNA regulating the expression of cancer-type amino acid transporter LAT1:its potential as an antionco-miRNA

    Xingming Liu, Ryuichi Ohgaki, Hiroki Okanishi, Suguru Okuda, Yoshikatsu Kanai

    The 136th Kinki Branch Meeting of the Japanese Pharmacological Society 2019/11/23

  83. PEPT1-targeted boron delivery for boron neutron capture therapy using BPA-containing dipeptide

    Junji Miyabe, Ryuichi Ohgaki, Keijiro Saito, Ling Wei, Lili Quan, Chunhuan Jin, Xingming Liu, Suguru Okuda, Shushi Nagamori, Hiroshi Ohki, Kazuo Yoshino, Hidenori Inohara, Yoshikatsu Kanai

    The 92nd Annual Meeting of the Japanese Pharacological Society 2019/03/15

  84. Suppression of tumor angiogenesis by inhibition of LAT1 in stromal endothelial cells

    Lili Quan, Ryuichi Ohgaki, Suguru Okuda, Shushi Nagamori, Hitoshi Endou, Yoshikatsu Kanai

    The 92nd Annual Meeting for the Japanese Pharmacological Society 2019/03/15

  85. Comparative phosphoproteomics between non-competitive and competitive inhibitions of L-type amino acid transporter 1 in cancer cells.

    Pornparn Kongpracha, Pattama Wiriyasermkul, Yoko Tanaka, Suguru Okuda, Ryuichi Ohgaki, Yoshikatsu Kanai, Shushi Nagamori

    The 92nd Annual Meeting for the Japanese Pharmacological Society 2019/03/14

  86. Critical moieties of aromatic amino acids for the interaction with organic anion transporter OAT1: Implications for reducing the renal background in tumor imaging

    Chunhuan Jin, Ling Wei, Ryuichi Ohgaki, Hideyuki Tominaga, Suguru Okuda, Shushi Nagamori, Youshikatsu Kanai

    The 92nd Annual Meeting for the Japanese Pharmacological Society 2019/03/14

  87. Molecular mechanism of substrate recognition by Leucine-Specific Binding Protein

    Yu Ma, Wiriyasermkul Pattama, Suguru Okuda, Ryuichi Ohgaki, Shushi Nagamori, Yoshikatsu Kanai

    The 92nd Annual Meeting for the Japanese Pharmacological Society 2019/03/14

  88. Effects of amino acid availability on the intracellular free amino acid concentration

    Kou Nishikubo, Ryuichi Ohgaki, Hiroki Okanishi, Suguru Okuda, Yoshikatsu Kanai

    The 92nd Annual Meeting for the Japanese Pharmacological Society 2019/03/14

  89. Suppression of colorectal cancer cell growth by combinational inhibition of amino acids transporters

    Bihui He, Kou Nishikubo, Ryuichi Ohgaki, Hiroki Okanishi, Suguru Okuda, Yoshikatsu Kanai

    The 92nd Annual Meeting for the Japanese Pharmacological Society 2019/03/14

  90. Anti-tumor effects of L-type amino acid transporter 1 (LAT1) inhibitor in a syngeneic and orthotropic mouse model for melanoma

    Zitong Shi, Ryuichi Ohgaki, Kazuko Kaneda, Suguru Okuda, Shushi Nagamori, Endou Hitoshi, Yoshikatsu Kanai

    The 92nd Annual Meeting for the Japanese Pharmacological Society 2019/03/14

  91. Structural requirement of aromatic amino acid derivatives specifically delivered to cancer cells with avoiding renal accumulation

    Chunhuan Jin, Ling Wei, Ryuichi Ohgaki, Hideyuki Tominaga, Suguru Okuda, Shushi Nagamori, Yoshikatsu Kanai

    第134回 日本薬理学会近畿部会 2018/11/23

  92. ペプチドトランスポーターを標的としたホウ素中性子捕捉療法に用いる新規ペプチド型ホウ素化合物の検討

    宮部淳二, 大垣隆一, 齋藤桂似郎, Wei Ling, 奥田傑, 永森收志, 大木寛, 吉野和夫, 猪原秀典, 金井好克

    第133回 日本薬理学会近畿部会 2018/06/01

  93. BPA-dipeptides, novel boron delivery agents for boron neutron capture therapy, targeting the oligopeptide transporters

    Junji Miyabe, Ryuichi Ohgaki, Keijiro Saito, Ling Wei, Suguru Okuda, Shushi Nagamori, Kazuo Yoshino, Hidenori Inohara, Yoshikatsu Kanai

    大阪大学医学系研究フォーラム 第10回若手研究フォーラム 2018/03/14

  94. Critical moieties of aromatic amino acid for renal accumulation of tumor imaging probes

    Chunhuan Jin, Ling Wei, Ryuichi Ohgaki, Hideyuki Tominaga, Suguru Okuda, Shushi Nagamori, Yoshikatsu Kanai

    2017/11/24

  95. LAT1 in endothelial cells as a novel target of anti-angiogenic cancer therapy

    Lili Quan, Ryuichi Ohgaki, Suguru Okuda, Shushi Nagamori, Yoshikatsu Kanai

    2017/11/24

  96. Non-competitive LAT1 inhibitors suppress mTORC1 signaling similary to competitive LAT1 inhibitors

    Pornparn Kongpracha, Suguru Okuda, Ryuichi Ohgaki, Yoshikatsu Kanai, Shushi Nagamori

    2017/11/24

  97. Structure-activity relations of aromatic amino acid derivatives to interact with organic anion transporter OAT1 reveal critical moieties for renal accumulation of tumor imaging probes

    Chunhuan Jin, Ling Wei, Ryuichi Ohgaki, Hideyuki Tominaga, Suguru Okuda, Shushi Nagamori, Yoshikatsu Kanai

    大阪大学医学系研究フォーラム 第10回若手研究フォーラム 2017/09/20

  98. Phosphoproteomics reveals the cellular processes affected by leucine transported through LAT1, a cancer type amino acid transporter”.

    Pornparn Kongpracha, Pattama Wiriyasermkul, Suguru Okuda, Ryuichi Ohgaki, Shushi Nagamori, Yoshikatsu Kanai

    2017/07/27

  99. Structure-activity relationship of novel inhibitors for cancer type amino acid transporter LAT1

    Pornparn Kongpracha, Pattama Wiriyasermkul, Kazuko Kaneda-Nakashima, Suguru Okuda, Ryuichi Ohgaki, Shushi Nagamori, Yoshikatsu Kanai

    2017/06/30

  100. A C-terminus mutation of SLC7A9 amino acid transporter retains substrate binding but diminishes the transport activity.

    Nagamori S, Kawamoto Y, Wiriyasermkul P, Nakagomi S, Okuda S, Ohgaki R, Kanai Y

    Gordon Research Conference: Mechanisms of Membrane Transport 2017/06/28

  101. SGLT2阻害薬カナグリフロジンによる 腎刷子縁膜タンパク質の発現変動の 網羅的定量プロテオミクスを用いた解析

    永森 收志, 齊藤 隆太, 五十棲 規嘉, 栗山 千亜紀, 塩谷 正治, 大垣 隆一, 奥田 傑, 金井 好克

    第60回 日本糖尿病学会年次学術集会 2017/05/19

  102. Structure-activity relations of aromatic amino acid derivatives to interact with organic anion transporter OAT1 reveal critical moieties for renal accumlation of imaging probes

    The 90th Annual Meeting of the Japanese Pharmacological Society 2017/03/15

  103. Relations between the recognition of leucine derivatives by LAT1 and the activation of mTORC1-mediated signaling

    The 90th Annual Meeting of the Japanese Pharmacological Society 2017/03/15

  104. アミノ酸トランスポーターLAT1阻害によるがん転移抑制効果の検討

    兼田 加珠子, 魏 玲, Pornparn Kongpracha, 大垣 隆一, 永森 收志, 金井 好克

    第130回 日本薬理学会近畿部会 2016/11/19

  105. アミノ酸トランスポーターLAT1による基質認識とmTORC1シグナル活性化に必要なロイシンの構造部位の決定

    奥田 傑, Pattama Wiriyasermkul, 大垣 隆一, 永森 收志, 金井 好克

    第130回 日本薬理学会近畿部会 2016/11/16

  106. SLC3A1( rBAT)の“missing partner”であった近位尿細管新規シスチントランスポーター

    永森收志, ウィリヤサムクン パッタマ, 奥山裕久, エスピノゴーチ メリチェル, 中込咲綾, 高藤和輝, 大垣隆一, 黒川洵子, パラシン マニュエル, 金井好克

    日本尿路結石症学会第26回学術集会 2016/07/20

  107. Interaction of halogenated aromatic amino acid probes for tumor imaging with renal organic anion transporter OAT1: the mechanisms of renal accumulation of the imaging probes

    Ling Wei, 大垣 隆一, 富永 英之, Quan Lili, 兼田(中島, 加珠子, 奥田 傑, 永森 收志, 金井 好克

    第129回 日本薬理学会近畿部会 2016/06/24

  108. Interaction of potential hepatotoxic ingredients of Traditional Chinese Medicine with liver drug transporters OATP1B1 and MDR1

    Lili Quan, Zijie Song, Yueqing Zhou, Ryuichi Ohgaki, Shushi Nagamori, Xin He, Yoshikatsu Kanai

    2016/05/21

  109. Involvements of LRRC8A and amino acid transporter SLC proteins in the activity of volumesensitive outwardly rectifying anion channel (VSOR)

    Toshiaki Okada, Ravshan Z. Sabirov, Ryuichi Ohgaki, Shushi Nagamori, Yoshikatsu Kanai, Koh Ono, Hiromi Uramoto, Yasunobu Okada

    2016/03/22

  110. 新規アミノ酸輸送体阻害薬による抗腫瘍効果の検討

    兼田(中島, 加珠子, 野崎泰俊, 疋田隼人, Pornparn Kongpracha、Ling Wei, 大垣隆一, 永森收志, 竹原徹郎, 金井好克

    BMB2015 2015/12/03

  111. Leucine transported by a cancer-type amino acid transporter LAT1 affects multiple cellular processes in pancreatic cancer cells

    Pornparn Kongprahca, Noriyoshi Isozumi, Pattama Wiriyasermkul, Kazuko Kaneda-Nakashima, Suguru Okuda, Ryuichi Ohgaki, Shushi Nagamori, Yoshikatsu Kanai

    BMB2015 2015/12/02

  112. アミノ酸トランスポーター阻害薬による抗腫瘍薬作用増強効果についての検討

    兼田加珠子, Pornparn Kongpracha、Ling Wei, 大垣 隆一, 永森 收志, 金 井 好克

    第37回 生体膜と薬物の相互作用シンポジウム 2015/11/19

  113. アミノ酸輸送体阻害薬による抗がん剤作用増強効果についての検討

    兼田加珠子, Pornparn Kongpracha、Ling Wei, 大垣 隆一, 永森 收志, 金井 好克

    第24回 日本Cell Death学会 2015/07/11

  114. Transport of 3-fluoro-L-α-methyl-tyrosine (FAMT) by organic ion transporters: a possible cause of renal background in 18F-FAMT PET

    2015/06/26

  115. Inhibition of the LAT1-mediated leucine transport affects multiple cellular processes in pancreatic cancer cells.

    Pornparn Kongprach, Pattama Wiriyasermkul, Noriyoshi Isozumi, Printip Wongthai, Suguru Okuda, Kenjiro Tadagaki, Ryuichi Ohgaki, Shushi Nagamori, Yoshikatsu Kanai

    2015/05/16

  116. CELLULAR UPTAKE OF 4-BORONO-L-PHENYLALANINE, A 10B CARRIER OF BORON NEUTRON CAPTURE THERAPY, DEPENDS ON THE EXPRESSION OF CANCER TYPE AMINO ACID TRANSPORTER LAT1

    Printip Wongthai, Kohei Hagiwara, Pattama Wiriyasermkul, Noriyoshi Isozumi, Ryuichi Ohgaki, Shushi Nagamori, Yoshikatsu Kanai

    2015/03/19

  117. Suppression of cancer-type amino acid transporter LAT1 affects multiple cellular events in pancreatic cancer cells

    Pornparn Kongpracha, Pattama Wiriyasermkul, Noriyoshi Isozumi, Printip Wongthai, Kazuko Kaneda-Nakashima, Suguru Okuda, Ryuichi Ohgaki, Shushi Nagamori, Yoshikatsu Kanai

    2015/03/19

  118. 3-fluoro-L--methyltyrosine (FAMT) PETにおける18F-FAMTの腎臓集積の分子機序の解明

    Ling Wei, Hideyuki Tominaka, Pattama Wiriyasermkul, Ryuichi Ohgaki, Kohei Hagiwara, Suguru Okuda, Shushi Nagamori, Yoshikatsu Kanai

    第88回 日本薬理学会年会 2015/03/18

  119. 膜輸送複合体transportsome における輸送機能共役の解析 —再構成プロテオリポソームによる実証

    永森收志, 大垣隆一, 金井好克

    第2回 生体界面研究会 2015/02/20

  120. 線虫の幼虫発生および寿命の調節における腸管特異的アミノ酸トランスポーターAAT-6の役割

    村田 大輔, 大垣 隆一, 萩原 浩平, 永森 收志, 金井 好克

    第37回 日本分子生物学会年会 2014/11/26

  121. [14C]-L-FAMTを用いた腫瘍細胞型アミノ酸トランスポーター LAT1の活性測定法の開発

    富永英之, Ling Wei, 織内昇, Pattama Wiriyasermkul, 大垣隆一, 永森收志, 金井好克, 伊藤浩, 宇川義一, 宍戸文男, 竹之下誠一

    第54回 日本核医学会学術総会・第34回 日本核医学技術学会総会学術大会 2014/11/06

  122. Inhibition of cancer-type amino acid transporter LAT1 affects multiple cellular events in pancreatic cancer cells

    Pornparn Kongprach, Pattama Wiriyasermkul, Noriyoshi Isozumi, Printip Wongthai, Suguru Okuda, Kenjiro Tadagaki, Ryuichi Ohgaki, Shushi Nagamori, Yoshikatsu Kanai

    2014/10/24

  123. Transport mechanisms of 4-borono-phenylalanine as a 10B carrier of boron neutron capture therapy for cancers

    Printip Wongthai, Kohei Hagiwara, Yurika Miyoshi, Pattama Wiriyasermkul, Pornparn Kongpracha, Isozumi Noriyoshi, Ryuichi Ohgaki, Kenjiro Tadagaki, Kenji Hamase, Shushi Nagamori, Yoshikatsu Kanai

    The 61st Japanese Biochemical Society Kinki branch 2014/05/17

  124. Interaction of a novel SGLT2 inhibitor Canagliglozin with human SGLT2

    2014/04/22

  125. Evaluation of amino acid transporter LAT1 as a molecular target of anti-tumor therapy by means of the combination of comprehensive proteomics and transport assay.

    永森 收志, Pattama Wiriyasermkul, 五十棲 規嘉, o, arn Kongpracha, 大垣 隆一, 金井 好克

    第87回日本薬理学会年会 2014/03/21

  126. Mechanisms of tumor cell uptake of 4-borono-phenylalanine, a 10B carrier of boron neutron capture therapy, mediated by system L amino acid transporters.

    Printip Wongthai, Kohei Hagiwara, Yurika Miyoshi, Pattama Wiriyasermkul, Pornparn Kongpracha, Isozumi Noriyoshi, Ryuichi Ohgaki, Kenjiro Tadagaki, Kenji Hamase, Shushi Nagamori, Yoshikatsu Kanai

    第87回日本薬理学会年会 2014/03/19

  127. 線虫アミノ酸トランスポーターAAT-6の輸送機能および細胞内局在の解析.

    村田 大輔, 大垣 隆一, 萩原 浩平, Kanokporn Phetdee, 永森 收志, 魏 玲, 平 田 拓, 野村 一也, 三谷 昌平, 金井 好克

    第36回日本分子生物学会年会 2013/12/04

  128. Involvement of amino acid transporter in vascular endothelial cell tube formation.

    Saori Hara, Ryuichi Ohgaki, Printip Wongthai, Saya Nakagomi, Shushi Nagamori, Yoshikatsu Kanai

    生理学研究所研究会「細胞センサーの分子機構・相互関連・ネットワーク 研究会」 2013/11/28

  129. Transport of 4-borono-L-phenylalanine, a 10B carrier of boron neutron capture therapy, by system L amino acid transporters.

    Printip Wongthai, Kohei Hagiwara, Yurika Miyoshi, Pattama Wiriyasermkul, Ryuichi Ohgaki, Kenjiro Tadagaki, Kenji Hamase, Shushi Nagamori, Yoshikatsu Kanai

    第124回日本薬理学会近畿部会 2013/11/01

  130. アミノ酸トランスポーターLAT1阻害による血管内皮細胞 チューブ形成への影響についての検討.

    原 早織, 大垣 隆一, Printip Wongthai, 中込 咲綾, 永森 收志, 金井 好克

    第124回日本薬理学会近畿部会 2013/11/01

  131. Expression and functional profiles of amino acid transporters in cancer cell lines.

    Pattama Wiriyasermkul, Shushi Nagamori, Noriyoshi Isozumi, Ryuichi Ohgaki, Hideyuki Tominaga, Yoshikatsu Kanai

    第86回日本生化学会年会 2013/09/12

  132. 3-Fluoro-L-a-methyltyrosine (FAMT), a positron emission tomography probe for cancer diagnosis, is a selective substrate of cancer-specific amino acid transporter L-type amino acid transporter 1 (LAT1).

    2013/07/12

  133. 線虫腸管細胞におけるアミノ酸トランスポーターAAT-6の頂端膜局在に寄与するトランスポートソーム

    村田 大輔, 大垣 隆一, 萩原 浩平, Kanokporn Phetdee, 永森 收志, 平田 拓, 野村 和子, 野村 一也, 三谷 昌平, 金井 好克

    第8回トランスポーター研究会年会 2013/06/15

  134. 質量分析計と再構成プロテオリポソームを用いた新規トランスポーター複合体の解析-腎尿細管に残さ れた第二のシスチントランスポーターの分子同定

    永森收志, 奥山 裕久, Pattama Wiriyasermkul, 中 込 咲綾, 西中 由美子, 高藤 和輝, 大垣 隆一, 金 井 好克

    第85回日本生化学会大会 2012/12/15

  135. 腎近位尿細管の第二のシスチントランスポーターの分子同定と機能解析

    永森收志, 奥山 裕久, Pattama Wiriyasermkul, 中 込 咲綾, 西中 由美子, 高藤 和輝, 大垣 隆一, 金 井 好克

    2012年度 生理研研究 2012/12/01

  136. 足場タンパク質PDZK1 上におけるNa+依存アニオン輸送体SMCT2 と 尿酸-アニオン交換体URAT1 の機能共役

    永森收志, 梅村康浩, Pattama Wiriyasermkul, 中込咲綾, 西中由美子, 高藤和輝, 大垣隆一, 木村徹, 金井好克

    2011 年度生理学研究所研究会「上皮細胞の恒常性維持機構におけるイオン・物質輸送の新しい分子生理」 2011/11/22

  137. オルガネラ局在型Na+/H+交換輸送体NHE6とNHE7の局在化決定部位の解析

    福良尚美, 大垣隆一, 中村徳弘, 三井慶治, 松下昌史, 金澤浩

    BMB2008 (第31回 日本分子生物学会年会、第81回日本生化学会大会合同大会) 2008

  138. 高等動物Na+/H+交換輸送タンパク質NHEの局在化

    松下昌史, 福良尚美, 佐野由枝, 大垣隆一, 中村徳弘, 三井慶治, 金澤浩

    日本生体エネルギー研究会 第31回討論会 2005

  139. オルガネラ局在型Na+/H+交換輸送体の局在化決定部位の解析

    福良尚美, 大垣隆一, 中村徳弘, 三井慶治, 松下昌史, 金澤浩

    第28回 日本分子生物学会年会 2005

  140. ヒトNa+/H+交換輸送体(NHE6-NHE9)の細胞内分布とその機能

    中村徳弘, 大垣隆一, 手古吉法, 福良尚美, 金澤浩

    文部科学省特定領域研究“膜輸送ナノマシーン”班会議 2004

  141. Molecular analysis of localization mechanism of Na+/H+ exchanger isoforms on post-Gogi compartments.

    Norihiro Nakamura, Naomi Fukura, Ryuichi Ohgaki, Keiji Mitsui, Hiroshi Kanazawa

    2004

  142. がん細胞におけるアミノ酸トランスポーターLAT1の阻害はp38 MAPK活性化を介したサイクリンD1の下方制御によりG0/G1期からS 期への移行を抑制する

    Zhou Xinyu, 大垣 隆一, Jin Chunhuan, Xu Minhui, 岡西 広樹, 遠藤 仁, 金井 好克

    第144回 日本薬理学会近畿部会 2024/03/20

  143. 膵臓がん及び胆管がん細胞に対するアミノ酸トランスポーターLAT1阻害薬nanvuranlatと細胞障害性抗がん薬の併用効果の検討

    西窪 航, 大垣 隆一, 劉 星明, 岡西 広樹, 徐 旻憓, 遠藤 仁, 金井 好克

    第143回 日本薬理学会近畿部会 2023/06/24

  144. Suppression of proliferation of cholangiocarcinoma cells by miRNAs targeting L-type amino acid transporter 1 downregulated in cholangiocarcinomas

    劉星明, 大垣隆一, 岡西広樹, 奥田傑, 徐旻恵, 金井好克

    第139回 日本薬理学会近畿部会 2021/06/26

  145. Development of tumor-specific compounds avoiding renal uptake for PET imaging and targeted α-therapy

    Chunhuan Jin, Ling Wei, Ryuichi Ohgaki, Suguru Okuda, Minhui Xu, Hiroki Okanishi, Shushi Nagamori, Yoshikatsu Kanai

    2020/11/14

  146. 遊離アミノ酸量の定量的経時変化解析によるアミノ酸トランスポーター阻害効果の検討

    西窪 航, 大垣 隆一, 岡西 広樹, 奥田 傑, 金井 好克

    第137回 日本薬理学会近畿部会 2020/06/20

Media Coverage 1

  1. An Exosome Protein Sets the Stage for a Cancer Biomarker

    LabX Media Group

    2025/01/15

Academic Activities 2

  1. International Training Program (ITP) Symposium 2009 at Groningen“Toward Brain Circulation through Research-Based Educational Collaboration and Exchange with EU”

    Osaka University, Graduate School of Science (OU-GSS) Osaka University, Office for International Pla

    2009/12 -

  2. ITP/ICI ECP symposium2009

    Graduate School of Science/Engineering Science, Office for International Planning Affair Board

    2009/03 -

Other 10

  1. 日本薬理学会 薬理学エデュケーター

    2020/01 - Present

  2. 日本薬理学会 次世代の会運営委員 副代表

    2024/04 - 2025/03

  3. Association of Next Generation Scientists in Japanese Pharmacological Society

    2018/05 - 2025/03

  4. 大阪大学大学院医学系研究科附属 共同研究実習センター運営委員

    2021/04 - 2023/03

  5. 大阪大学大学院医学系研究科 動物実験施設運営委員

    2020/04 - 2023/03

  6. 第95回 日本薬理学会年会 若手研究者キャリア形成支援プログラム WG代表

    2022/03 -

  7. 第93回 日本薬理学会年会 若手研究者キャリア形成支援プログラム WG代表

    2020/03 -

  8. 第92回 日本薬理学会年会 若手研究者キャリア形成支援プログラム WG代表

    2019/03 -

  9. 第92回 日本薬理学会年会 実行委員

    2019/03 -

  10. 第132回 日本薬理学会近畿部会 事務局長

    2017/11 -

Institutional Repository 1

Content Published in the University of Osaka Institutional Repository (OUKA)
  1. Ion transport mechanism and regulation of Na+/H+ exchangers

    大垣 隆一